Literature DB >> 29743307

Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.

Adoracion Pegalajar-Jurado1, Martin E Schriefer1, Ryan J Welch2, Marc R Couturier2,3, Tiffany MacKenzie4, Rebecca J Clark1, Laura V Ashton1, Mark J Delorey1, Claudia R Molins5.   

Abstract

Standard two-tiered testing (STTT) is the recommended algorithm for laboratory diagnosis of Lyme disease (LD). Several limitations are associated with STTT that include low sensitivity in the early stages of disease, as well as technical complexity and subjectivity associated with second-tier immunoblotting; therefore, modified two-tiered testing (MTTT) algorithms that utilize two sequential first-tier tests and eliminate immunoblotting have been evaluated. Recently, a novel MTTT that uses a VlsE chemiluminescence immunoassay followed by a C6 enzyme immunoassay has been proposed. The purpose of this study was to evaluate the performance of the VlsE/C6 MTTT using well-characterized serum samples. Serum samples from the CDC Lyme Serum Repository were tested using three MTTTs, VlsE/C6, whole-cell sonicate (WCS)/C6, and WCS/VlsE, and three STTTs (immunoblotting preceded by three different first-tier assays: VlsE, C6, and WCS). Significant differences were not observed between the results of the MTTTs assessed; however, the VlsE/C6 MTTT resulted in the highest specificity (100%) when other diseases were tested and the lowest sensitivity (75%) for LD samples. Significant differences were present between the results for various MTTTs and STTTs evaluated. Specifically, all MTTTs resulted in higher sensitivities than the STTTs for all LD groups combined and were significantly more accurate (i.e., higher proportion of correct classifications) for this group, with the exception of the WCS/ViraStripe STTT. Additionally, when other diseases were tested, only the results of the VlsE/C6 MTTT differed significantly from those of the WCS/ViraStripe STTT, with the VlsE/C6 MTTT resulting in a 6.2% higher accuracy. Overall, the VlsE/C6 MTTT offers an additional laboratory testing algorithm for LD with equivalent or enhanced performance compared to that of the other MTTTs and STTTs evaluated in this study.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Borrelia burgdorferi; Lyme disease; immunoserology; two-tiered testing

Mesh:

Substances:

Year:  2018        PMID: 29743307      PMCID: PMC6062810          DOI: 10.1128/JCM.01943-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Lyme Disease Diagnosis: Serology.

Authors:  Martin E Schriefer
Journal:  Clin Lab Med       Date:  2015-12       Impact factor: 1.935

Review 2.  Clinical practice. Early Lyme disease.

Authors:  Gary P Wormser
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

3.  Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.

Authors:  John A Branda; Klemen Strle; Lise E Nigrovic; Paul M Lantos; Timothy J Lepore; Nitin S Damle; Mary Jane Ferraro; Allen C Steere
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

Review 4.  Erythema migrans.

Authors:  Robert B Nadelman
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

5.  Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.

Authors:  J R Zhang; J M Hardham; A G Barbour; S J Norris
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

6.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

7.  Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.

Authors:  Claudia R Molins; Mark J Delorey; Christopher Sexton; Martin E Schriefer
Journal:  J Clin Microbiol       Date:  2016-08-24       Impact factor: 5.948

8.  Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.

Authors:  M B Lawrenz; J M Hardham; R T Owens; J Nowakowski; A C Steere; G P Wormser; S J Norris
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 9.  Lyme disease: diagnostic issues and controversies.

Authors:  Maria E Aguero-Rosenfeld; Gary P Wormser
Journal:  Expert Rev Mol Diagn       Date:  2014-12-08       Impact factor: 5.225

Review 10.  STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness.

Authors:  Edwin J Masters; Chelsea N Grigery; Reid W Masters
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

View more
  20 in total

1.  Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.

Authors:  Ian R C Davis; Shelly A McNeil; Wanda Allen; Donna MacKinnon-Cameron; L Robbin Lindsay; Katarina Bernat; Antonia Dibernardo; Jason J LeBlanc; Todd F Hatchette
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

2.  A Fully Automated Multiplex Assay for Diagnosis of Lyme Disease with High Specificity and Improved Early Sensitivity.

Authors:  Johnnie B Hahm; John W Breneman; Jing Liu; Svetlana Rabkina; Weiming Zheng; Shuxia Zhou; Roger P Walker; Ravi Kaul
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

3.  Evaluation of a Novel Microarray Immunoblot Assay for Detection of IgM- and IgG-Class Antibodies to Borrelia burgdorferi.

Authors:  Elitza S Theel; Marisa Sorenson; Dane Granger
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

4.  Expanding Access to Biospecimens for Lyme Disease Test Development.

Authors:  John L Schmitz
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

5.  Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers.

Authors:  Adriana R Marques
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 6.  Emerging Tick-Borne Diseases.

Authors:  Susan Madison-Antenucci; Laura D Kramer; Linda L Gebhardt; Elizabeth Kauffman
Journal:  Clin Microbiol Rev       Date:  2020-01-02       Impact factor: 26.132

Review 7.  Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2020-05-07

8.  Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease.

Authors:  M E (Ewoud) Baarsma; Jeanine Ursinus; Hans L Zaaijer; Herman Kuiper; Joppe W Hovius
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

Review 9.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

10.  Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex Format.

Authors:  Jack Reifert; Kathy Kamath; Joel Bozekowski; Ewa Lis; Elizabeth J Horn; Dane Granger; Elitza S Theel; John Shon; Jaymie R Sawyer; Patrick S Daugherty
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.